The closing price of Standard BioTools Inc (NASDAQ: LAB) was $2.70 for the day, down -0.37% from the previous closing price of $2.71. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 2609939 shares were traded. LAB stock price reached its highest trading level at $2.8000 during the session, while it also had its lowest trading level at $2.6250.
Ratios:
Our analysis of LAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on July 12, 2023, initiated with a Overweight rating and assigned the stock a target price of $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when Casdin Partners Master Fund, L bought 1,403 shares for $2.62 per share. The transaction valued at 3,669 led to the insider holds 11,497,928 shares of the business.
Casdin Partners Master Fund, L bought 250,000 shares of LAB for $642,500 on Mar 04 ’24. The Director now owns 11,496,525 shares after completing the transaction at $2.57 per share. On May 19 ’23, another insider, Casdin Partners Master Fund, L, who serves as the Director of the company, bought 800,000 shares for $2.29 each. As a result, the insider paid 1,835,920 and bolstered with 1,200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 1.03B and an Enterprise Value of 1.02B. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.37. Its current Enterprise Value per Revenue stands at 9.55 whereas that against EBITDA is -18.66.
Stock Price History:
Over the past 52 weeks, LAB has reached a high of $3.16, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 2.5038, while the 200-Day Moving Average is calculated to be 2.3798.
Shares Statistics:
LAB traded an average of 1.88M shares per day over the past three months and 1.93M shares per day over the past ten days. A total of 290.12M shares are outstanding, with a floating share count of 282.68M. Insiders hold about 2.56% of the company’s shares, while institutions hold 63.79% stake in the company. Shares short for LAB as of Mar 15, 2024 were 9.26M with a Short Ratio of 4.94, compared to 8.06M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.19% and a Short% of Float of 3.40%.
Earnings Estimates
The firm’s stock currently is rated by 1 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.01 and -$0.01 for the fiscal current year, implying an average EPS of -$0.01. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
